Integra LifeSciences Holdings Corporation, a leading global medical technology company, today announced that it has launched SurgiMend PRS Meshed Collagen Matrix, its latest offering in tissue-building solutions for plastic and reconstructive surgery.
SurgiMend PRS Meshed Collagen Matrix is an expandable matrix that provides up to twice the initial coverage area once hydrated and fully expanded. It features a meshing pattern which allows for vascular ingrowth and increased conformability.
“With the market trending toward the utilization of larger acellular dermal matrices, we are excited to now offer SurgiMend PRS Meshed Collagen Matrix as an innovative solution for plastic and reconstructive surgeons,” said Robert T. Davis, Jr., corporate vice president and president, Orthopedics and Tissue Technologies.
About SurgiMend PRS Meshed Collagen Matrix
SurgiMend PRS Meshed Collagen Matrix is intended for implantation to reinforce soft tissue where weakness exists and for surgical repair of damaged or ruptured soft tissue membranes. SurgiMend PRS Meshed is specifically indicated for plastic and reconstructive surgery. SurgiMend PRS Meshed will be available in a 20 centimeters X 10 centimeters configuration that expands to approximately 18 centimeters X 22 centimeters when hydrated and fully expanded.
